Steroids that contain a ketone group at position 17.
DrugDrug NameDrug Indication
DB00655EstroneFor management of perimenopausal and postmenopausal symptoms.
DB0143419-norandrostenedioneThe claim that supplemental 19-norandrostenedione has anabolic effects is unsubstantiated.
DB014565-androstenedioneNot Available
DB01536AndrostenedioneNot Available
DB01708PrasteroneDHEA is taken as a supplement for a variety of unsubstantiated indications. The following indications have shown promise and are backed up by some scientific evidence: schizophrenia (DHEA may be more effective in women than men); improving the appearance of older people’s skin (taking DHEA by mouth seems to increase skin thickness and moisture, and decrease facial “age spots” in elderly men and women); improving ability to achieve an erection in men with sexual dysfunction. Additionally, DHEA has shown promise in improving symptoms of lupus (SLE). Taking DHEA by mouth along with conventional treatment may help reduce the number of times symptoms flare up and may allow a reduction in the dose of prescription drugs needed. DHEA may also help SLE symptoms such as muscle ache and mouth ulcers. DHEA also seems to strengthen bones in SLE patients being treated with high-dose steroids (corticosteroids). DHEA also shows promise in the treatment of osteoporosis. Taking DHEA by mouth daily seems to improve bone mineral density (BMD) in older women and men with osteoporosis or osteopenia (pre-osteoporosis). DHEA may also increase BMD in young women with the eating disorder called anorexia nervosa. DHEA is often prescribed in India for the induction of ovulation to improve chances of pregnancy.
DB02187EquilinFor the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)
DB03515EquileninNot Available
DB04574Estrone sulfateEstropipate is used for the treatment of moderate to severe vasomotor symptoms associated with the monopause, and moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. It is also used to treat hypoestrogenism due to hypogonadism, castration or primary ovarian failure, and prevent postmenopausal osteoporosis.
DB04870Oleoyl-estroneFor the treatment of obesity.
DB0510716-BromoepiandrosteroneInvestigated for use/treatment in cystic fibrosis, HIV infection, hepatitis (viral, B), and malaria.
DB05212HE3286For the treatment of rheumatoid arthritis and type 2 diabetes.
DB05804Prasterone sulfateInvestigated for use/treatment in asthma and burns and burn infections.
DB06157IstaroximeInvestigated for use/treatment in heart disease.
DB06250FluasteroneInvestigated for use/treatment in psoriasis and psoriatic disorders, hyperlipidemia, metabolic disease, cancer/tumors (unspecified), and obesity.
DB08905FormestaneFor the treatment of estrogen-receptor positive breast cancer in post-menopausal women.
DB12194AtamestaneNot Available
DrugDrug NameTargetType
DB00655EstroneEstrogen receptor alphatarget
DB00655EstroneCytochrome P450 1A2enzyme
DB00655EstroneCytochrome P450 1A1enzyme
DB00655EstroneSerum albumincarrier
DB00655EstroneSolute carrier organic anion transporter family member 2B1transporter
DB00655EstroneMultidrug resistance protein 1transporter
DB00655EstroneSolute carrier organic anion transporter family member 1A2transporter
DB00655EstroneATP-binding cassette sub-family G member 2transporter
DB00655EstroneSolute carrier organic anion transporter family member 1B1transporter
DB00655EstroneCytochrome P450 3A4enzyme
DB00655EstroneCytochrome P450 1B1enzyme
DB00655EstroneCytochrome P450 2B6enzyme
DB00655EstroneCytochrome P450 2C9enzyme
DB00655EstroneCytochrome P450 2E1enzyme
DB00655EstroneCytochrome P450 3A5enzyme
DB00655EstroneCytochrome P450 4A11enzyme
DB00655EstroneEstrogen receptor betatarget
DB00655EstroneAndrogen receptortarget
DB00655EstroneCytochrome P450 19A1target
DB00655EstroneSex hormone-binding globulintarget
DB00655EstroneSolute carrier family 22 member 8transporter
DB014565-androstenedioneCytochrome P450 3A4enzyme
DB01536AndrostenedioneAldo-keto reductase family 1 member C3target
DB01536AndrostenedioneEstradiol 17-beta-dehydrogenase 1target
DB01536Androstenedione6-deoxyerythronolide B hydroxylasetarget
DB01536Androstenedione3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1target
DB01536AndrostenedioneCytochrome P450 3A4enzyme
DB01708PrasteroneSteroid Delta-isomerasetarget
DB01708PrasteroneBile salt sulfotransferasetarget
DB01708PrasteroneCholesterol oxidasetarget
DB01708PrasteroneEstradiol 17-beta-dehydrogenase 1target
DB01708PrasteroneSulfotransferase family cytosolic 2B member 1target
DB01708PrasteroneCytochrome P450 3A4enzyme
DB01708PrasteroneCytochrome P450 3A7enzyme
DB01708PrasteronePeroxisome proliferator-activated receptor alphatarget
DB01708PrasteroneEstrogen receptor alphatarget
DB01708PrasteroneSigma non-opioid intracellular receptor 1target
DB01708PrasteroneEstrogen receptor betatarget
DB01708PrasteroneNuclear receptor subfamily 1 group I member 2target
DB01708PrasteroneNuclear receptor subfamily 1 group I member 3target
DB01708PrasteroneGABA-A receptor (anion channel)target
DB01708PrasteroneNMDA receptortarget
DB01708PrasteroneAndrogen receptortarget
DB02187EquilinEstradiol 17-beta-dehydrogenase 1target
DB02187EquilinEstrogen receptor alphatarget
DB02187EquilinCytochrome P450 3A4enzyme
DB03515EquileninSteroid Delta-isomerasetarget
DB03515EquileninSteroid Delta-isomerasetarget
DB03515EquileninCytochrome P450 3A4enzyme
DB04574Estrone sulfateCytochrome P450 1A2enzyme
DB04574Estrone sulfateCytochrome P450 3A4enzyme
DB04574Estrone sulfateEstrogen receptor alphatarget
DB04574Estrone sulfateEstrogen receptor betatarget
DB04574Estrone sulfateSex hormone-binding globulincarrier
DB04574Estrone sulfateSerum albumincarrier
DB04574Estrone sulfateCytochrome P450 2C9enzyme
DB04574Estrone sulfateMultidrug and toxin extrusion protein 1transporter
DB04574Estrone sulfateMultidrug and toxin extrusion protein 2transporter
DB0510716-BromoepiandrosteroneGlucose-6-phosphate 1-dehydrogenasetarget
DB05212HE3286Nuclear factor NF-kappa-B p105 subunittarget
DB05212HE3286Nuclear factor NF-kappa-B p100 subunittarget
DB05212HE3286Cytochrome P450 3A4enzyme
DB05804Prasterone sulfateCytochrome P450 19A1enzyme
DB05804Prasterone sulfateCytochrome P450 3A7enzyme
DB05804Prasterone sulfateProstaglandin G/H synthase 2enzyme
DB05804Prasterone sulfateSolute carrier family 22 member 8transporter
DB05804Prasterone sulfateSolute carrier organic anion transporter family member 1A2transporter
DB05804Prasterone sulfateSolute carrier organic anion transporter family member 1B1transporter
DB05804Prasterone sulfateSolute carrier organic anion transporter family member 1B3transporter
DB05804Prasterone sulfateSolute carrier organic anion transporter family member 2B1transporter
DB05804Prasterone sulfateSolute carrier family 10 member 6transporter
DB05804Prasterone sulfateBile salt export pumptransporter
DB06157IstaroximeSarcoplasmic/endoplasmic reticulum calcium ATPase 2target
DB06157IstaroximeSodium/potassium-transporting ATPase subunit alpha-1target
DB08905FormestaneCytochrome P450 3A4enzyme